|
|
 |
 |
 |
|
|
|||
|
||||
|
||||
Novedades en el Tratamiento Topico de HPVFrom: Isaac Melo (imeloc@cybermex.net)Fri, 17 Apr 1998 16:29:12 -0500 (CDT)
Estimado Ricardo Realmente el producto (aldara) promete muchas ventajas para el tratamiento de la conmdilomatosis perinel. Aun se requiere mas experiencia en su uso. Te envío 10 referencias bibliograficas. 1.-Cellular requirements for cytokine production in response to the immunomodulators imiquimod and S-27609. Gibson SJ; Imbertson LM; Wagner TL; Testerman TL; Reiter MJ; Miller RL; Tomai MA Interferon Cytokine Res, 15:537-45, 1995 Jun 2.-A phase I clinical trial of imiquimod' an oral interferon inducer' administered daily. Savage P; Horton V; Moore J; Owens M; Witt P; Gore ME Br J Cancer, 74:1482-6, 1996 Nov 3.-Stimulation of interferon and cytokine gene expression by imiquimod and stimulation by Sendai virus utilize similar signal transduction pathways [Megyeri K; Au WC; Rosztoczy I; RaJ NB; Miller RL; Tomai MA; Pitha PM Mol Cell Biol, 15:2207-18, 1995 Apr 4.-Cytokine induction by the immunomodulators imiquimod and S-27609. Testerman TL; Gerster JF; Imbertson LM; Reiter MJ; Miller RL; Gibson SJ; Wagner TL; Tomai MA J Leukoc Biol, 58:365-72, 1995 Sep 5.-Effect of a novel topical immunomodulator' S-28463' on keratinocyte cytokine gene expression and production. FuJisawa H; ShivJi GM; Kondo S; Wang B; Tomai MA; Miller RL; Sauder DN J Interferon Cytokine Res, 16:555-9, 1996 Jul 6.-Therapeutic approaches to genital warts. Beutner KR; Ferenczy A Am J Med, 102:28-37, 1997 May 5
Voltar para Administrador da lista: flavio.monteiro.desouza@obgyn.net Solicitações à lista: obstet-l-request@obgyn.net Última atualização: Mon May 19 16:35:49 2008 |
|
